Biolab Zolpidem Orodispersible 1.0 mg, 1.75 mg and 3.5 mg to Treat Maintenance Insomnia Disorder.

Clinical trial NCT03885141 · UNKNOWN

Trial details

NCT number: NCT03885141
Sponsor: Biolab Sanus Farmaceutica
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Insomnia Disorder

Start date: 2021-03-01
Primary completion: 2021-12-01
Enrollment: 366

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.